标普和纳斯达克内在价值 联系我们

Ayala Pharmaceuticals, Inc. ADXS OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
26/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Ayala Pharmaceuticals, Inc. (ADXS) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 26/100 其中 1/7 项标准通过。

SharesGrow 7-Criteria Score
26/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
75/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
护城河
15/100
→ Income
~
成长
58/100
→ Income
收入
10/100
→ Income

估值概览 — ADXS

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率279.45
EV/EBITDA0.0
每股数据
EPS (TTM)$-7.99
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2014 $-14.49 $1M $-16.53M -1652.5%
2015 $-25.17 $0.00 $-47.03M -
2016 $-31.17 $3.99M $-73.56M -1841.3%
2017 $-34.58 $12.03M $-93.44M -776.6%
2018 $-19.37 $6.06M $-66.52M -1097.1%
2019 $-93.60 $2.33M $-17.79M -762.3%
2020 $-34.71 $253K $-26.47M -10462.1%
2021 $-11.07 $3.24M $-17.86M -551.3%
2022 $-7.90 $250K $-14.36M -5743.6%
2023 $-7.99 $13K $-48.07M -369784.6%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言